Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CELLINK publishes prospectus in connection with its listing on Nasdaq Stockholm

CELLINK AB (publ) (“CELLINK” or the “Company”) (CELLINK is listed on Nasdaq First North Growth Market under CLNK B) announced on April 3, 2020, that Nasdaq Stockholm’s listing committee had approved that the Company’s shares are admitted to trading on Nasdaq Stockholm’s Main Market, following the fulfilment of customary conditions. Today, on April 15, 2020, the prospectus that has been prepared by the Company in connection with the listing was approved and registered by the Swedish Financial Supervisory Authority (“SFSA”) and is now available on CELLINK’s website, www.cellink.com, and on

Invitation to presentation of BioArctic’s Interim Report for the first quarter 2020 on April 22 at 9.30 a.m. CET

Stockholm, Sweden, April 15, 2020 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B)to publish the company’s Interim Report for the period January – March 2020 onWednesday, April 22, 2020, at 08:00 a.m. CET. BioArctic invites to an audiocast with teleconference (in English) for investors, analystsand media on April 22, at 09:30 CET. Gunilla Osswald, CEO, and Jan Mattsson, CFO, to present BioArctic and comment onthe Interim Report for the period January – March 2020 followed by a Q&A-session. To attend, please dial-in at one of the numbers below, from: Sweden: + 46 8 505

The Board of Directors of Concentric AB withdraws proposal of dividend and instead proposes no dividend to the shareholders.

The Board of Directors of Concentric AB has decided to withdraw the previously communicated dividend proposal of SEK 4.50 to the Annual General Meeting on April 23, 2020. The Board instead proposes that no dividend is distributed to the shareholders for the 2019 financial year. At the same time, the Nomination Committee has chosen to withdraw the previously announced proposal to increase Board fees, instead proposing to maintain current Board fees. Due to the current market situation caused by COVID-19, the Board of Directors has prioritized maintaining financial flexibility. Provided

TagMaster launches a new RFID reader for parking and access control – XT-5

Press release, Stockholm, Sweden 15 April 2020TagMaster, the leading supplier of advanced sensor systems for Smart Cities within Traffic and Rail, launches a new advanced RFID reader, XT-5, for identification in parking and access control solutions. The XT-5 is marketed in two versions - one designed according to the European specification and one according to the US specification. XT-5 is an RFID reader designed and optimized for solutions in the access control area and for parking applications such as; · Airport car parks · Rail yards and bus depots · Automated truck

Increased order intake for NOTE's plant in Norrtälje

NOTE continues to increase within medtech. One of NOTE's existing customers has placed an extended order of SEK 30 million for immediate delivery in the second and third quarters. The product is used in the intensive care and the need has increased considerably during the current pandemic. The order means that the volume for the customer will double during 2020 and the prospect that the high rate of production continues is expected to be good. “We are pleased that we continue to grow within medtech, which is a segment where we have grown a lot in recent years, and it fits well into

Scandinavian Enviro Systems (publ) is conducting a private placement of approximately MSEK 32.5 as part of a strategic partnership with Michelin

The Board of Directors of Scandinavian Enviro Systems (Enviro), has in accordance with a letter of intent regarding a long-term strategic partnership with the French global tyre manufacturer Michelin, today resolved to conduct a private placement of approximately MSEK 32.5, by which Michelin (through its wholly-owned subsidiary Michelin Ventures SAS) will subscribe for shares in Enviro corresponding to holdings of 20% after the issue. The strategic partnership is intended to include, among other things, the establishment of a jointly owned recycling plant for end-of-life tyres and joint

OrganoClick publish its Annual Report 2019

OrganoClick's Annual Report for 2019 is now available on OrganoClick's homepage, www.organoclick.com.Shareholders and other can receive a printed copy of the Annual Report on demand by contacting the company at: OrganoClick AB (publ) Linjalvägen 9 187 66 Täby  or by mailing ir@organoclick.com   ......................................................................................... For more information, please contact: Mårten Hellberg, CEO 0707 - 16 48 90, marten.hellberg@organoclick.com……………………………………………………………… About OrganoClick OrganoClick AB (publ) is a

NOTICE OF ANNUAL GENERAL MEETING IN Alzinova AB (publ)

Shareholders in Alzinova AB (publ) are hereby invited to attend the Annual General Meeting (“AGM”) on 14 May 2020, at 14.00 CEST in Gula salongen, at Göteborgs Universitet, with the adress Universitetsplatsen 1, Göteborg. Registration starts at 13.30 CEST and will stop when the meeting starts.The company monitors the situation regarding covid-19, the corona virus, closely and will provide further information closer to the AGM if it is deemed necessary to take any special measures at the AGM due to the risk of spreading the virus. The complete notice of the AGM, which is attached in the

Small components play a large role in medical equipment

Several of the companies within the Lesjöfors Group have many years of experience supplying the medical industry. We would like to introduce some examples of spring products specially manufactured for this industry of current interest.Highly demanded medical components European Springs & Pressings in the UK is one of the Lesjöfors companies with customers in the medical industry. Their medical range includes springs that go into the mouthpieces for ventilators, catheter clips to syringe drivers, patient beds and trolley systems, instrumentation and numerous electrical components for

Alzinova publishes the Annual Report for 2019

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the Annual Report of the financial year 2019.The Annual Report, which is attached in the press release, can also be downloaded from the company’s Swedish website, www.alzinova.se   For more information, please contact: Kristina Torfgård, CEO Telephone: +46 70 846 79 75 E-mail: kristina.torfgard@alzinova.com Certified Adviser: Corpura Fondkommission AB E-mail: ca@corpura.se Telephone: 0768-532822 Website: www.corpura.se   About Alzinova AB Alzinova AB is engaged in

AlzeCure Pharma publishes its Annual Report for 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2019 has been published. The Annual Report is attached as a PDF and is available on the company’s website,For more information, please contact Martin Jönsson, CEO Tel: +46 707 86 94 43 martin.jonsson@alzecurepharma.com The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on April 15, 2020.  About AlzeCure Pharma AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in innovative drug research with a primary focus on

Invitation to conference call with web presentation of Cloetta AB´s interim report Q1 2020

Cloetta AB will publish the interim report for the period 1 January – 31 March 2020 on Friday 24 April 2020 at 8 a.m. CET. Following this report Cloetta will organize a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. Time for the publication of the interim reportFriday 24 April at 08:00 a.m. CET  Time for conference call and web presentationFriday 24

KONE UltraRope® to feature in a new luxury hotel tower in Nanjing, China

KONE Corporation, press release, April 15, 2020 KONE Corporation, a global leader in the elevator and escalator industry, will deliver People Flow® solutions – including 36 elevators and the revolutionary KONE UltraRope® hoisting technology – to a new high-rise development in Nanjing, the capital of the Jiangsu province in eastern China.  The new building will rise up to 416.6 meters and host a Kimpton Hotel. It will become the tallest of the planned five high-rise buildings in the Nanjing Financial City Complex and the structurally tallest building in the entire city. Once

Elisa: Interim Report Q1 2020 publication on 22 April 2020

ELISA CORPORATION INVESTOR NEWS 15 APRIL 2020 AT 9:00 AMElisa will publish its Q1 2020 interim report from January–March on Wednesday 22 April 2020 at approximately 8:30 am EET (6:30 UK time). International conference call for analysts and investors will be held on the same day at 12:00 pm EET. Dial-in numbers for the conference call, PIN: 44230774#FI: +358981710310SE: +46 856642651UK: +44 3333000804US: +18558570686 Audiocast: https://elisa.videosync.fi/2020-q1-results The presentations will be available on elisa.com/investors  at

Elkem ASA – Notice of annual general meeting 2020

Oslo, 15 April 2020 The annual general meeting of Elkem ASA will be held on Friday 8 May 2020 at 09:00 (Norwegian time) at Felix Conference Centre, Bryggetorget 3, Vika in Oslo.  The full notice is attached, and all relevant documents can be found on www.elkem.com/investor This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.   For further information:Odd-Geir Lyngstad,VP Finance & Investor RelationsTel: +47 976 72 806Email: odd-geir.lyngstad@elkem.no About ElkemFounded in 1904, Elkem is one of

Hansa Biopharma to host conference call to provide interim results for the first quarter of 2020 and business update

Lund, Sweden April 15, 2020. Hansa Biopharma will publish its interim report for January-March 2020 at 8:00 a.m. CET on April 28, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 2:00 p.m. CET. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be

Tobii’s Annual Report 2019 Available on the Website

Tobii AB (publ) has today published its Annual Report for 2019 on the website. The document includes Tobii's Sustainability Report and Corporate Governance Report. The Annual Report is available in Swedish and English on Tobii’s website under financial reports . The fiscal year covers the period January 1 to December 31, 2019. This information is information that Tobii AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication on April 15, 2020, at 08:00 a.m. CET.

Vicore Pharma publishes the Annual Report for 2019

Gothenburg, April 15, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announced the publication of the Annual Report 2019.The Annual Report is available on the company’s website: https://vicorepharma.com/investors/financial-reports/. For further information, please contact:Hans Jeppsson, CFO, tel: +46 70 553 14 65, hans.jeppsson@vicorepharma.com    This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Securities Markets Act. The

Invitation to Kungsleden’s presentation of the first quarter 2020

On Thursday, 23 April 2020, at 7:00 a.m. (CET), Kungsleden AB (publ) will publish its interim report for January–March 2020.Accordingly, Kungsleden invites investors, asset managers, financial analysts and the press to a presentation of the interim report, where CEO Biljana Pehrsson and CFO Magnus Jacobsson will comment on the first quarter. The report will be published at 7:00 a.m. and will be available to download at www.kungsleden.se/financialreports Follow the presentation via telephone conference or audio broadcast at 8:45 a.m. The presentation will be held in English via a

Invitation to the presentation of Swedbank’s interim report January – March 2020

Swedbank’s interim report for January – March 2020 will be published on Thursday 23 Aprilat 7.00 a.m. (Swedish time).Investors and analysts: Conference call on 23 April at 8.00 a.m. (Swedish time)Jens Henriksson, President and CEO, Anders Karlsson, CFO, Lars-Erik Danielsson, Chief Credit Officer and Gregori Karamouzis, Head of Investor Relations will present the report. The conference call will be held in English and broadcasted live on www.swedbank.com/ir, where a recording also will be available following the call.To participate in the conference call, dial +46 8 566 42651 or +44

Trading update 1st quarter 2020

Medicover AB (publ)  issues a trading update due to Covid-19 crisis before it releases its interim announcement as planned on the 30[th] April 2020. · First quarter revenue reached €238.8m (€199.7m), up 19.6% on prior year with organic revenue growth of 5.8%. · Healthcare Services revenue reached €133.8m (€102.9m) up 30.1% on prior year with organic revenue growth of 6.3%. · Diagnostic Services revenue reached €108.1m (€100.2m) up 7.9% on prior year with organic revenue growth of 4.9%. · Operating profit was €6.4m (€11.3m) an operating margin of 2.7% (

Skanska builds part of the UK’s new high speed railway, HS2, for GBP 1.12 billion, about SEK 13.9 billion

Skanska, as part of the Skanska Costain STRABAG joint venture, has signed a contract with HS2 Ltd to commence full detailed design and construction of Phase 1 of the UK’s new high speed railway in the southern section of the overall project. Skanska will include GBP 1.12 billion, about SEK 13.9 billion, in the order bookings for Europe for the second quarter 2020.The contract involves the design and construction of major tunnels in the approach to the London terminus at Euston station. To date, the joint venture’s contract with HS2 Ltd has been to undertake scheme design and site

Konecranes publishes its January-March interim report on April 29, 2020

KONECRANES PLC PRESS RELEASE April 15, 2020 at 09:00 EEST Konecranes publishes its January-March interim report on April 29, 2020Konecranes will publish its January-March 2020 Interim Report on Wednesday, April 29, 2020 at 9.00 a.m. Finnish time. The report will be available on the company’s website at www.konecranes.com after publishing.A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 11:00 a.m. EEST. The event will be held in English. The January – March 2020 Interim report will be presented by CEO Rob Smith and

Outokumpu appoints Heikki Malinen as President and CEO

Outokumpu Oyj                                                       Stock exchange releaseApril 15, 2020 at 9.00 am EESTOutokumpu appoints Heikki Malinen as President and CEO Outokumpu’s Board of Directors has appointed Heikki Malinen, M.Sc. (Econ.), MBA (Harvard), as President and CEO of Outokumpu and the Chairman of the Leadership Team. He will join the company on May 1 and assume his role as the CEO on May 16, 2020. Heikki Malinen has previously worked as CEO in Posti Group Corporation and in Pöyry PLC. Prior to these, he has held various leadership positions in UPM in the USA and

There are no items matching the current filter
There are no more items matching the current filter
Back to top